07/06/2023
Midsona will publish its interim report January-June 2023 on 20 July 2023 at 8am CEST. A presentation of the report will be held the same day at 11am CEST via telephone conference or audio cast.
Midsona invites investors, financial analysts, and media to a presentation where CEO Peter Åsberg and CFO Max Bokander will comment on the report. The presentation will be held at 11am CEST and can be followed via telephone conference or audiocast. The report will be published at 8am CEST and will be available at
https://www.midsona.se/en/investors/reports/
The presentation is in English and is followed by a question-and-answer session. Questions can be asked orally via the conference call. The webcast can be accessed via the link below.
https://ir.financialhearings.com/midsona-q2-2023
To attend the presentation via teleconference and to ask questions, please klick on the link. After your registration you will receive a dial-in number and a conference ID:
https://conference.financialhearings.com/teleconference/?id=200867
After the presentation, a recorded version will be available on:
https://www.midsona.se/en/investors/reports/
20 July 2023 Half year financial report January-June 2023
26 October 2023 Interim report January-September 2023
1 February 2024 Year-end report 2023
25 April 2024 Interim report January-March 2024
The financial calendar is also published on:
https://www.midsona.se/en/investors/calendar/
FOR MORE INFORMATION, PLEASE CONTACT:
Peter Åsberg, CEO and President
Telefon: +46 730 26 16 32
E-post: peter.asberg@midsona.com
Max Bokander, CFO
Telefon: +46 708 65 13 64
E-post: max.bokander@midsona.com
ABOUT MIDSONA
Midsona develops and markets strong brands within health and well-being, with products that help people live a healthier and more sustainable life, with an increased understanding of the origin of the raw material and with transparency as to the content. The Midsona share is listed on Nasdaq OMX Stockholm. For more information www.midsona.com/en
Dokument och länkar
Press release - Invitation to presentation of Q2 2023